Antenatal Corticosteroids for Late-Preterm Infants: A Decision-Analytic and Economic Analysis

Table 6

Number of cases of chronic disease prevented and dollars saved through administration of ACS to hypothetical late-preterm birth cohort, assuming base-case estimates and late-preterm birth rate approximately 331,500 infants.

Outcomes	No ACS with labor (Reference)	ACS with labor
Chronic respiratory disease
Cases (𝑛)	23205	19956
Case prevented (𝑛)	Reference	3249
Cost saved ($ millions)	Reference	55.3
Neurodevelopmental delay
Cases (𝑛)	816	522
Cases prevented (𝑛)	Reference	294
Cost saved ($ millions)	Reference	78.0
Death in childhood
Cases (𝑛)	2128	1447
Cases prevented (𝑛)	Reference	681
Cost saved ($ millions)	Reference	32.9

ACS: antenatal corticosteroids.